BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38368035)

  • 1. Genetic Testing in Hypertrophic Cardiomyopathy.
    Ireland CG; Ho CY
    Am J Cardiol; 2024 Feb; 212S():S4-S13. PubMed ID: 38368035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Testing in Patients with Hypertrophic Cardiomyopathy.
    Bonaventura J; Polakova E; Vejtasova V; Veselka J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity.
    de Feria AE; Kott AE; Becker JR
    Open Heart; 2021 Feb; 8(1):. PubMed ID: 33637569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
    Girolami F; Bardi S; Berti L; Cecchi F; Servettini E; Tomberli B; Torricelli F; Olivotto I
    Recenti Prog Med; 2011 Dec; 102(12):486-93. PubMed ID: 22258194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of centre expertise on the diagnosis and management of hypertrophic cardiomyopathy: A study from the French register of hypertrophic cardiomyopathy (REMY).
    Mirabel M; Damy T; Donal E; Huttin O; Labombarda F; Eicher JC; Cervino C; Laurito M; Offredo L; Tafflet M; Jouven X; Giura G; Desnos M; Jeunemaître X; Empana JP; Charron P; Habib G; Réant P; Hagège A;
    Int J Cardiol; 2019 Jan; 275():107-113. PubMed ID: 30316646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.
    Mazzarotto F; Girolami F; Boschi B; Barlocco F; Tomberli A; Baldini K; Coppini R; Tanini I; Bardi S; Contini E; Cecchi F; Pelo E; Cook SA; Cerbai E; Poggesi C; Torricelli F; Walsh R; Olivotto I
    Genet Med; 2019 Feb; 21(2):284-292. PubMed ID: 29875424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy.
    Ahluwalia M; Ho CY
    Heart; 2021 Feb; 107(3):183-189. PubMed ID: 33172912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
    Chung H; Kim Y; Cho SM; Lee HJ; Park CH; Kim JY; Lee SH; Min PK; Yoon YW; Lee BK; Kim WS; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY; Lee KA
    Mitochondrion; 2020 Jul; 53():48-56. PubMed ID: 32380161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics: Yield and Clinical Significance.
    Hoss S; Habib M; Silver J; Care M; Chan RH; Hanneman K; Morel CF; Iwanochko RM; Gollob MH; Rakowski H; Adler A
    Circ Genom Precis Med; 2020 Apr; 13(2):e002748. PubMed ID: 32150461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
    Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
    J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
    Hathaway J; Heliö K; Saarinen I; Tallila J; Seppälä EH; Tuupanen S; Turpeinen H; Kangas-Kontio T; Schleit J; Tommiska J; Kytölä V; Valori M; Muona M; Sistonen J; Gentile M; Salmenperä P; Myllykangas S; Paananen J; Alastalo TP; Heliö T; Koskenvuo J
    BMC Cardiovasc Disord; 2021 Mar; 21(1):126. PubMed ID: 33673806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification.
    Stafford F; Thomson K; Butters A; Ingles J
    Curr Cardiol Rep; 2021 Jan; 23(2):9. PubMed ID: 33433738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy.
    Bos JM; Will ML; Gersh BJ; Kruisselbrink TM; Ommen SR; Ackerman MJ
    Mayo Clin Proc; 2014 Jun; 89(6):727-37. PubMed ID: 24793961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy.
    Al-Thihli K; Ebrahim H; Hughes DA; Patel M; Tipple M; Salvarinova R; Gardiner J; Vallance H; Waters PJ
    Gene; 2012 Apr; 497(2):320-2. PubMed ID: 22336178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Versus Targeted Genetic Testing in Children with Hypertrophic Cardiomyopathy.
    Bales ND; Johnson NM; Judge DP; Murphy AM
    Pediatr Cardiol; 2016 Jun; 37(5):845-51. PubMed ID: 26936621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy.
    Khouzam A; Kwan A; Baxter S; Bernstein JA
    J Genet Couns; 2015 Oct; 24(5):797-809. PubMed ID: 25566741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy.
    Lakdawala NK; Olivotto I; Day SM; Han L; Ashley EA; Michels M; Ingles J; Semsarian C; Jacoby D; Jefferies JL; Colan SD; Pereira AC; Rossano JW; Wittekind S; Ware JS; Saberi S; Helms AS; Cirino AL; Leinwand LA; Seidman CE; Ho CY
    Circ Genom Precis Med; 2021 Feb; 14(1):e003062. PubMed ID: 33284039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.